Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Vigil Neuroscience, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 58
- +4 vs. Q1 2024
- Shares held
- 26.1M
- −385.3K (−1.5%) vs. Q1 2024
- Total value
- $104.5M
- +$14.0M (+15.4%) vs. Q1 2024
- New holders
- 20
- 13 more added
- Sold out
- 16
- 17 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 16 | $0 | 0.00% | +15+1,500.0% | Added |
| Nisa Investment Advisors, LLC | 75 | $300 | 0.00% | +75 | New |
| New York State Common Retirement Fund | 140 | $560 | 0.00% | −10,000−98.6% | Reduced |
| Federated Hermes, Inc. | 198 | $792 | 0.00% | −119−37.5% | Reduced |
| Macquarie Group Ltd | 831 | $3.32K | 0.00% | +831 | New |
| Russell Investments Group, Ltd. | 2,029 | $8.12K | 0.00% | +2,029 | New |
| Citigroup Inc | 2,411 | $9.64K | 0.00% | −64,899−96.4% | Reduced |
| Rhumbline Advisers | 2,588 | $10.4K | 0.00% | −15,365−85.6% | Reduced |
| FMR LLC | 2,896 | $11.6K | 0.00% | +1,246+75.5% | Added |
| Cubist Systematic Strategies, LLC | 3,653 | $14.6K | 0.00% | +3,653 | New |
| Catalyst Funds Management Pty Ltd | 4,100 | $16.4K | 0.00% | +4,100 | New |
| UBS Group AG | 4,808 | $19.2K | 0.00% | −11,343−70.2% | Reduced |
| Point72 (DIFC) Ltd | 5,506 | $22.0K | 0.00% | +5,506 | New |
| Acadian Asset Management LLC | 6,598 | $26.0K | 0.00% | +6,598 | New |
| Mirae Asset Global ETFs Holdings Ltd. | 8,135 | $32.5K | 0.00% | +8,135 | New |
| JPMorgan Chase & Co | 9,137 | $36.5K | 0.00% | +2,021+28.4% | Added |
| Prelude Capital Management, LLC | 10,867 | $43.5K | 0.00% | −9,510−46.7% | Reduced |
| Tower Research Capital LLC (TRC) | 11,765 | $47.1K | 0.00% | +5,976+103.2% | Added |
| Two Sigma Investments, LP | 12,065 | $48.3K | 0.00% | −32,933−73.2% | Reduced |
| Paloma Partners Management Co | 16,609 | $66.4K | 0.01% | +16,609 | New |
| Morgan Stanley | 19,841 | $79.4K | 0.00% | −3,521−15.1% | Reduced |
| Royal Bank of Canada | 20,455 | $82.0K | 0.00% | +20,088+5,473.6% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 21,854 | $87.4K | 0.02% | +21,854 | New |
| Bank of America Corp | 26,797 | $107.2K | 0.00% | +7,858+41.5% | Added |
| Walleye Capital LLC | 27,575 | $110.3K | 0.00% | +27,575 | New |
| Qube Research & Technologies Ltd | 30,429 | $121.7K | 0.00% | +30,429 | New |
| Centiva Capital, LP | 32,800 | $131.2K | 0.01% | +32,800 | New |
| Y-Intercept (Hong Kong) Ltd | 38,364 | $153.5K | 0.01% | +38,364 | New |
| State Street Corp | 40,739 | $163.0K | 0.00% | −245,324−85.8% | Reduced |
| PEAK6 Investments LLC | 41,486 | $165.9K | 0.01% | 00.0% | Unchanged |
| Barclays PLC | 44,755 | $179.0K | 0.00% | −68,281−60.4% | Reduced |
| Alpine Global Management, LLC | 44,893 | $179.6K | 0.03% | +44,893 | New |
| Susquehanna International Group, LLP | 48,051 | $192.2K | 0.00% | +48,051 | New |
| Jane Street Group, LLC | 62,354 | $249.4K | 0.00% | +62,354 | New |
| Renaissance Technologies LLC | 71,500 | $286.0K | 0.00% | +11,536+19.2% | Added |
| Bridgeway Capital Management, LLC | 80,064 | $320.3K | 0.01% | +22,100+38.1% | Added |
| Northern Trust Corp | 133,603 | $534.4K | 0.00% | −5,117−3.7% | Reduced |
| Geode Capital Management, LLC | 159,371 | $637.6K | 0.00% | −174,871−52.3% | Reduced |
| Woodline Partners LP | 206,614 | $826.5K | 0.01% | +206,614 | New |
| ArrowMark Colorado Holdings LLC | 289,460 | $1.16M | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 334,807 | $1.34M | 0.00% | +301,678+910.6% | Added |
| Ensign Peak Advisors, Inc | 395,116 | $1.58M | 0.00% | +166,442+72.8% | Added |
| Goldman Sachs Group Inc | 401,139 | $1.60M | 0.00% | +382,900+2,099.3% | Added |
| BlackRock Inc. | 405,043 | $1.62M | 0.00% | −471,989−53.8% | Reduced |
| OrbiMed Advisors LLC | 448,891 | $1.80M | 0.04% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.89M | 0.06% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $2.24M | 1.72% | 00.0% | Unchanged |
| Deep Track Capital, LP | 597,215 | $2.39M | 0.07% | −997,716−62.6% | Reduced |
| StemPoint Capital LP | 744,412 | $2.98M | 0.88% | +744,412 | New |
| Vanguard Group Inc | 814,731 | $3.26M | 0.00% | −79,742−8.9% | Reduced |
| 683 Capital Management, LLC | 1,100,000 | $4.40M | 0.46% | +105,100+10.6% | Added |
| Citadel Advisors LLC | 1,443,159 | $5.77M | 0.01% | −722,652−33.4% | Reduced |
| Point72 Asset Management, L.P. | 1,485,000 | $5.94M | 0.02% | +1,485,000 | New |
| Sphera Funds Management Ltd. | 1,692,166 | $6.77M | 1.10% | −38,248−2.2% | Reduced |
| BVF Inc | 1,813,633 | $7.25M | 0.20% | 00.0% | Unchanged |
| Artal Group S.A. | 1,828,691 | $7.31M | 0.19% | +17,500+1.0% | Added |
| Northpond Ventures, LLC | 4,214,498 | $16.9M | 30.50% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $23.3M | 2.46% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −980,311−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −71,815−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −33,368−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −45,750−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −41,968−100.0% | Sold out |
| Nuveen Asset Management, LLC | 0 | $0 | 0.00% | −26,840−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −24,100−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −19,178−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −7,919−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −5,655−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,554−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −1,327−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −542−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −4−100.0% | Sold out |